Understanding Disparities in Melanoma Diagnosis
Black men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.
Progress Against Cancer
Black men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.
The FDA has approved another T-cell engager therapy for patients with heavily pretreated multiple myeloma The U.S. Food and Drug Administration (FDA) has granted accelerated approval to elranatamab-bcmm (Elrexfio) for the treatment of adult...
The FDA approved a combination of the PARP inhibitor niraparib with a hormone therapy agent for certain patients with metastatic prostate cancer The U.S. Food and Drug Administration (FDA) has approved the combination of...
Research links testicular cancer in military firefighters to ‘forever chemicals,’ and older women who are screened for breast cancer at risk for overdiagnosis.
The FDA granted full approval to pralsetinib as a treatment for certain patients with non-small cell lung cancer The U.S. Food and Drug Administration has granted full approval to pralsetinib (Gavreto) to treat adult...
Certain patients with advanced multiple myeloma may be eligible for treatment with a new immunotherapy drug. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to talquetamab-tgvs (Talvey) for patients with multiple...
Genetic testing can help establish inherited cancer risk, and a new cancer registry tracks breast and prostate cancer in people of African origin.
The FDA approved a combination of trifluridine, tipiracil, and bevacizumab for the treatment of heavily pretreated metastatic colorectal cancer. The U.S. Food and Drug Administration (FDA) has approved trifluridine and tipiracil (Lonsurf), in combination...
The FDA has approved an immune checkpoint inhibitor in combination with chemotherapy to treat certain adult patients with endometrial cancer The U.S. Food and Drug Administration (FDA) has approved dostarlimab-gxly (Jemperli) in combination with...
Less than four minutes of physical activity per day linked to lower cancer risk, and vaccination helped improve outcomes for cancer patients with COVID-19.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now